S. Muller

发表

CXCR3, Inflammation, and Autoimmune Diseases

Hélène Dumortier, S. Lacotte, S. Brun, 2009, Annals of the New York Academy of Sciences.

Epitope spreading in systemic lupus erythematosus: identification of triggering peptide sequences.

S. Muller, F. Monneaux, 2002, Arthritis and rheumatism.

Autoantigen microarrays for multiplex characterization of autoantibody responses

P. Brown, G. Pruijn, W. Robinson, 2002, Nature Medicine.

Modulation of microtubule assembly by the HIV-1 Tat protein is strongly dependent on zinc binding to Tat

Y. Mély, P. Didier, S. Muller, 2008, Retrovirology.

The mechanism of HIV-1 Tat-directed nucleic acid annealing supports its role in reverse transcription.

J. Darlix, C. Boudier, Y. Mély, 2010, Journal of molecular biology.

Functionalized carbon nanotubes are non-cytotoxic and preserve the functionality of primary immune cells.

M. Prato, G. Pastorin, S. Lacotte, 2006, Nano letters.

Cellular uptake of functionalized carbon nanotubes is independent of functional group and cell type.

M. Prato, G. Pastorin, S. Muller, 2007, Nature nanotechnology.

T Cell Response to Preproinsulin I and II in the Nonobese Diabetic Mouse1

C. Boitard, S. Muller, J. Briand, 2002, The Journal of Immunology.

Autophagy is dispensable for B-cell development but essential for humoral autoimmune responses

S. Muller, Johan Arnold, Diane Murera, 2015, Cell Death and Differentiation.

Guidelines for the use and interpretation of assays formonitoring autophagy (3rd edition)

Sangeeta Khare, Xin Qi, Ying Wang, 2016 .

Assessing Autophagy in Sciatic Nerves of a Rat Model that Develops Inflammatory Autoimmune Peripheral Neuropathies

S. Brun, S. Muller, J. de Seze, 2017, Cells.

Recent advances in solid-phase peptide synthesis and preparation of antibodies to synthetic peptides.

M. V. Van Regenmortel, S. Muller, J. Briand, 1990, Biologicals : journal of the International Association of Biological Standardization.

Immunization with peptide-functionalized carbon nanotubes enhances virus-specific neutralizing antibody responses.

Maurizio Prato, Alberto Bianco, Ed Kramer, 2003, Chemistry & biology.

Nanomaterials, Autophagy, and Lupus Disease

S. Muller, A. Bianco, 2016, ChemMedChem.

Resetting the autoreactive immune system with a therapeutic peptide in lupus

S. Muller, N. Schall, 2015, Lupus.

Peptide Nanostructured Conjugates for Therapeutics

S. Muller, Y. Frere, L. Danicher, 2013 .

Peptide-based approaches to treat lupus and other autoimmune diseases.

S. Muller, J. Briand, O. Chaloin, 2012, Journal of autoimmunity.

Lysosomes as a therapeutic target

S. Muller, Fengjuan Wang, S. Bonam, 2019, Nature Reviews Drug Discovery.

Influenza Virus-Induced Type I Interferon Leads to Polyclonal B-Cell Activation but Does Not Break Down B-Cell Tolerance

A. Korganow, S. Muller, F. Monneaux, 2007, Journal of Virology.

In Vivo Remodeling of Altered Autophagy-Lysosomal Pathway by a Phosphopeptide in Lupus

A. Cuervo, S. Muller, Fengjuan Wang, 2020, Cells.

What Has Come out from Phytomedicines and Herbal Edibles for the Treatment of Cancer?

S. Muller, V. Pandy, Y. Wu, 2018, ChemMedChem.

Antigenic mimicry of natural L-peptides with retro-inverso-peptidomimetics.

M. V. Van Regenmortel, S. Muller, J. Briand, 1994, Proceedings of the National Academy of Sciences of the United States of America.

Structural limitations to antigenic mimicry achievable with retroinverso (all-D-retro) peptides.

E. Giralt, M. V. Van Regenmortel, S. Muller, 1996, Trends in biotechnology.

The V3 loop-mimicking pseudopeptide 5[Kpsi(CH2N)PR]-TASP inhibits HIV infection in primary macrophage cultures.

S. Nisole, S. Muller, J. Briand, 1999, AIDS research and human retroviruses.

From Systemic Inflammation to Neuroinflammation: The Case of Neurolupus

S. Muller, Hélène Jeltsch-David, C. Po, 2018, International journal of molecular sciences.

Interfacing Functionalized Carbon Nanohorns with Primary Phagocytic Cells

M. Prato, S. Lacotte, S. Muller, 2008 .

OX40 Ligand Contributes to Human Lupus Pathogenesis by Promoting T Follicular Helper Response.

H. Ueno, V. Pascual, R. Coffman, 2015, Immunity.

LigandContributes to Human Lupus Pathogenesis by Promoting T Follicular Helper Response Graphical

H. Ueno, V. Pascual, R. Coffman, 2022 .

Heteroclitic properties of mixed α-and aza-β3-peptides mimicking a supradominant CD4 T cell epitope presented by nucleosome

S. Muller, J. Briand, J. Hoebeke, 2007 .

In vivo T helper cell response to retro-inverso peptidomimetics.

C. Leclerc, S. Muller, H. Dumortier, 1997, Journal of immunology.

Adamantane-based dendrons for trimerization of the therapeutic P140 peptide.

S. Muller, A. Bianco, G. Lamanna, 2014, Biomaterials.

Diminution of Circulating CD4+CD25high T Cells in Naïve Crohn’s Disease

M. Gaub, R. Baumann, S. Muller, 2009, Digestive Diseases and Sciences.

Immunomodulatory consequences of ODN CpG-polycation complexes.

S. Muller, A. Bianco, E. Moreau, 2009, Methods.

Pre-mRNA Processing Is Partially Impaired in Satellite Cell Nuclei from Aged Muscles

C. Zancanaro, S. Muller, C. Pellicciari, 2010, Journal of biomedicine & biotechnology.

Targeting VEGF-A with a vaccine decreases inflammation and joint destruction in experimental arthritis

S. Muller, H. Hlawaty, E. Assier, 2015, Angiogenesis.

Transcutaneous immunization with tetanus toxoid and mutants of Escherichia coli heat-labile enterotoxin as adjuvants elicits strong protective antibody responses.

R. Rappuoli, R. Tierney, S. Muller, 2003, The Journal of infectious diseases.

Dendrimers in immunotherapy and hormone therapy

S. Muller, P. Komirishetty, A. Areti, 2020 .

Rescue of autophagy and lysosome defects in salivary glands of MRL/lpr mice by a therapeutic phosphopeptide.

S. Muller, Fengjuan Wang, N. Schall, 2018, Journal of autoimmunity.

Assessing Autophagy in Mouse Models and Patients with Systemic Autoimmune Diseases

S. Muller, Fengjuan Wang, N. Schall, 2017, Cells.

Capability of Neutrophils to Form NETs Is Not Directly Influenced by a CMA-Targeting Peptide

S. Muller, A. Mahajan, J. Hahn, 2017, Front. Immunol..

Macroautophagy is deregulated in murine and human lupus T lymphocytes

A. Korganow, S. Muller, M. Decossas, 2012, Autophagy.

Applying peptide antigens onto bare skin: induction of humoral and cellular immune responses and potential for vaccination.

F. Brown, S. Muller, J. Briand, 2002, Journal of controlled release : official journal of the Controlled Release Society.

Parameters affecting the immunogenicity of a liposome‐associated synthetic hexapeptide antigen

M. V. Van Regenmortel, S. Muller, J. Briand, 1991, European journal of immunology.

Implication of a lysosomal antigen in the pathogenesis of lupus erythematosus.

A. Korganow, S. Muller, N. Schall, 2021, Journal of autoimmunity.

Identification of a Minimal T Cell Epitope Recognized by Antinucleosome Th Cells in the C-Terminal Region of Histone H41

S. Muller, J. Briand, P. Decker, 2000, The Journal of Immunology.

Synthetic peptides as tools for diagnosis and therapeutic strategies to treat systemic lupus erythematous.

S. Muller, 2012, Autoimmunity reviews.

Active immunization against murine TNFalpha peptides in mice: generation of endogenous antibodies cross-reacting with the native cytokine and in vivo protection.

J. Cavaillon, J. Zagury, S. Muller, 2004, Vaccine.

Lupuzor/P140 peptide in patients with systemic lupus erythematosus: a randomised, double-blind, placebo-controlled phase IIb clinical trial

J. Gómez-Reino, S. Muller, H. Scherbarth, 2012, Annals of the rheumatic diseases.

Autoantibodies against galectin-2 peptides as biomarkers for the antiphospholipid syndrome

D. Isenberg, M. Schiller, G. Schett, 2012, Lupus.

Deimination of linker histones links neutrophil extracellular trap release with autoantibodies in systemic autoimmunity

M. Radic, P. Thompson, S. Muller, 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

B cell epitopes of the heterogeneous nuclear ribonucleoprotein A2: identification of a new specific antibody marker for active lupus disease

G. Steiner, G. Schett, S. Muller, 2008, Annals of the rheumatic diseases.

Anti-“dividing cell antigen” autoantibody: A novel antinuclear antibody pattern related to histones in systemic lupus erythematosus

P. Youinou, S. Muller, M. Blaschek, 1993, Journal of Clinical Immunology.

The autoimmune response to chromatin antigens in systemic lupus erythematosus: autoantibodies against histone H1 are a highly specific marker for SLE associated with increased disease activity

G. Steiner, G. Schett, S. Muller, 2002, Lupus.

Key Sequences Involved in the Spreading of the Systemic Autoimmune Response to Spliceosomal Proteins

S. Muller, F. Monneaux, 2001, Scandinavian journal of immunology.

Immunity under the skin: potential application for topical delivery of vaccines.

S. Muller, J. Briand, C. Partidos, 2003, Vaccine.

Recognition of a subregion of human proinsulin by class I-restricted T cells in type 1 diabetic patients.

C. Boitard, S. Muller, J. Briand, 2005, Proceedings of the National Academy of Sciences of the United States of America.

High susceptibility to collagen-induced arthritis in mice lacking IFN-gamma receptors.

S. Huang, F. Batteux, S. Muller, 1997, Journal of immunology.

Parkinson's disease is an autoimmune disease: A reappraisal.

S. Muller, S. Bonam, 2020, Autoimmunity reviews.

The caveolin-1 binding domain of HIV-1 glycoprotein gp41 is an efficient B cell epitope vaccine candidate against virus infection.

S. Muller, J. Briand, C. Desgranges, 2004, Immunity.

Partially modified retro-inverso pseudopeptides as non-natural ligands for the human class I histocompatibility molecule HLA-A2.

S. Muller, J. Briand, G. Guichard, 1996, Journal of medicinal chemistry.

The Mitochondrion-lysosome Axis in Adaptive and Innate Immunity: Effect of Lupus Regulator Peptide P140 on Mitochondria Autophagy and NETosis

M. Radic, S. Muller, J. Poulton, 2018, Front. Immunol..

Autoimmunity, neuroinflammation, pathogen load: A decisive crosstalk in neuropsychiatric SLE.

S. Muller, Hélène Jeltsch-David, 2016, Journal of autoimmunity.

Early Differentiated CD138highMHCII+IgG+ Plasma Cells Express CXCR3 and Localize into Inflamed Kidneys of Lupus Mice

S. Lacotte, S. Brun, S. Muller, 2013, PloS one.

CD4 T cell autophagy is integral to memory maintenance

S. Muller, Johan Arnold, Diane Murera, 2018, Scientific Reports.

Role of peptide backbone in T cell recognition.

P. Kourilsky, J. Abastado, P. Bousso, 1999, Journal of immunology.

Molecular therapies for systemic lupus erythematosus: clinical trials and future prospects

S. Muller, F. Monneaux, 2009, Arthritis research & therapy.

Identification of V3 Loop-binding Proteins as Potential Receptors Implicated in the Binding of HIV Particles to CD4+Cells*

E. Dam, J. Blanco, S. Muller, 1998, The Journal of Biological Chemistry.

Isolation of histones and related chromatin structures from spermatozoa nuclei of a dasyurid marsupial, Sminthopsis crassicaudata.

J. Ausió, S. Muller, W. Breed, 1997, The Journal of experimental zoology.

Use of histone antibodies for studying chromatin topography and the phosphorylation of chromatin subunits.

M. V. Van Regenmortel, S. Muller, A. Mazen, 1984, The EMBO journal.

Single Insulin-Speci fi c CD 8 + T Cells Show Characteristic Gene Expression Pro fi les in Human Type 1 Diabetes

F. Lemonnier, J. Coste, C. Boitard, 2011 .

Expression of Preproinsulin-2 Gene Shapes the Immune Response to Preproinsulin in Normal Mice1

C. Boitard, J. Jami, S. Muller, 2004, The Journal of Immunology.

Normal Mice the Immune Response to Preproinsulin in Expression of Preproinsulin-2 Gene Shapes

C. Boitard, J. Jami, S. Muller, 2003 .

Acceleration of type 1 diabetes mellitus in proinsulin 2-deficient NOD mice.

C. Boitard, J. Jami, S. Muller, 2003, The Journal of clinical investigation.

Aberrant Expression of the Autoantigen Heterogeneous Nuclear Ribonucleoprotein-A2 (RA33) and Spontaneous Formation of Rheumatoid Arthritis-Associated Anti-RA33 Autoantibodies in TNF-α Transgenic Mice1

G. Kollias, G. Schett, S. Muller, 2005, The Journal of Immunology.

Peptide-based immunotherapy of systemic lupus erythematosus.

S. Muller, F. Monneaux, 2004, Autoimmunity reviews.

Function of CD4+,CD25+ Treg cells in MRL/lpr mice is compromised by intrinsic defects in antigen-presenting cells and effector T cells.

V. Parietti, S. Muller, F. Monneaux, 2008, Arthritis and rheumatism.

Regulatory T Cells and Systemic Lupus Erythematosus

V. Parietti, S. Muller, F. Monneaux, 2007, Annals of the New York Academy of Sciences.

B and T Cell Responses to the Spliceosomal Heterogeneous Nuclear Ribonucleoproteins A2 and B1 in Normal and Lupus Mice1

G. Steiner, S. Muller, H. Dumortier, 2000, The Journal of Immunology.

HSPA8/HSC70 in Immune Disorders: A Molecular Rheostat that Adjusts Chaperone-Mediated Autophagy Substrates

S. Muller, M. Ruff, S. Bonam, 2019, Cells.

Delineation of a neutralizing subregion within the immunodominant epitope (GH loop) of foot-and-mouth disease virus VP1 which does not contain the RGD motif.

M. V. Van Regenmortel, F. Brown, S. Muller, 1999, Vaccine.

Epigenetic Histone Code and Autoimmunity

S. Muller, J. Dieker, 2010, Clinical reviews in allergy & immunology.

Transcutaneous Immunization with Cross-Reacting Material CRM197 of Diphtheria Toxin Boosts Functional Antibody Levels in Mice Primed Parenterally with Adsorbed Diphtheria Toxoid Vaccine

R. Rappuoli, S. Muller, C. Partidos, 2008, Infection and Immunity.

Effect of Skin Barrier Disruption on Immune Responses to Topically Applied Cross-Reacting Material, CRM197, of Diphtheria Toxin

S. Muller, C. Partidos, M. Peyre, 2005, Infection and Immunity.

A partially modified retro-inverso pseudopeptide modulates the cytokine profile of CTL specific for an influenza virus epitope.

S. Muller, J. Briand, J. Hoebeke, 1998, Journal of immunology.

CTL Specific for an Influenza Virus Epitope Pseudopeptide Modulates the Cytokine Profile of A Partially Modified Retro-Inverso

S. Muller, J. Briand, J. Hoebeke, 1998 .

An Autophagy Modulator Peptide Prevents Lung Function Decrease and Corrects Established Inflammation in Murine Models of Airway Allergy

N. Frossard, S. Muller, F. Daubeuf, 2021, Cells.

Tat-neutralizing versus Tat-protecting antibodies in rhesus macaques vaccinated with Tat peptides.

B. Roques, S. Muller, E. Moreau, 2005, Vaccine.

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

Mark R. Marten, Erinna F. Lee, Dana L. Miller, 2021, Autophagy.

T Cell Response to Preproinsulin I and II in the Nonobese Diabetic Mouse

C. Boitard, S. Muller, J. Briand, 2002 .

The cell nuclei of skeletal muscle cells are transcriptionally active in hibernating edible dormice

C. Zancanaro, S. Muller, M. Malatesta, 2009 .

Anti-Ro(SSA) and anti-La(SSB) antibodies in autoimmune rheumatic diseases

P. Youinou, S. Muller, R. Humbel, 1994, Clinical reviews in allergy.

CIDP: Current Treatments and Identification of Targets for Future Specific Therapeutic Intervention

S. Brun, S. Muller, J. de Seze, 2022, Immuno.

Successful induction of protective antibody responses against Haemophilus influenzae type b and diphtheria after transcutaneous immunization with the glycoconjugate polyribosyl ribitol phosphate-cross-reacting material 197 vaccine.

R. Rappuoli, S. Muller, C. Partidos, 2004, The Journal of infectious diseases.

Modulation of immune responses with transcutaneously deliverable adjuvants.

S. Muller, J. Briand, C. Partidos, 2004, Vaccine.

The LTR72 Mutant of Heat-Labile Enterotoxin of Escherichia coli Enhances the Ability of Peptide Antigens To Elicit CD4+ T Cells and Secrete Gamma Interferon after Coapplication onto Bare Skin

R. Rappuoli, S. Muller, J. Briand, 2002, Infection and Immunity.

Serological abnormalities, including common idiotype PR4, in families with rheumatoid arthritis.

D. Isenberg, P. Youinou, S. Muller, 1989, Annals of the rheumatic diseases.

The double reactivity of a human monoclonal rheumatoid factor to IgG and histones is related to distinct binding sites

S. Muller, J. Pasquali, Thierry Martin, 1988, European journal of immunology.

T cell recognition and therapeutic effect of a phosphorylated synthetic peptide of the 70K snRNP protein administered in MRL/lpr mice

M. Patarroyo, S. Muller, F. Monneaux, 2003 .

Citrullinated Autoantigens: From Diagnostic Markers to Pathogenetic Mechanisms

M. Radic, S. Muller, 2015, Clinical Reviews in Allergy & Immunology.

the Nonobese Diabetic Mouse T Cell Response to Preproinsulin I and II in

C. Boitard, S. Muller, J. Briand, 2002 .

Heteroclitic properties of mixed alpha- and aza-beta3-peptides mimicking a supradominant CD4 T cell epitope presented by nucleosome.

S. Muller, J. Briand, J. Hoebeke, 2007, Molecular immunology.

New Zealand white rabbits immunized with RNA‐complexed total histones develop an autoimmune‐like response

S. Muller, J. Briand, M. H. Regenmortel, 1991, Clinical and experimental immunology.

Pathogenic anti-nucleosome antibodies

A. Tincani, S. Muller, P. Meroni, 2008, Lupus.

Detection of nucleosome particles in serum and plasma from patients with systemic lupus erythematosus using monoclonal antibody 4H7.

R. Williams, S. Muller, C. Malone, 2001, The Journal of rheumatology.

Immunization onto bare skin with synthetic peptides: immunomodulation with a CpG‐containing oligodeoxynucleotide and effective priming of influenza virus‐specific CD4+ T cells

S. Muller, J. Briand, C. Partidos, 2002, Immunology.

At least three linear regions but not the zinc-finger domain of U1C protein are exposed at the surface of the protein in solution and on the human spliceosomal U1 snRNP particle.

S. Muller, H. Dumortier, W. V. van Venrooij, 1998, Nucleic acids research.

Monoclonal autoantibodies to histones from autoimmune NZB/NZW F1 mice

M. V. Van Regenmortel, S. Muller, R. Laskov, 1984, European journal of immunology.

The lupus erythematosus cell phenomenon: comparative analysis of antichromatin antibody specificity in lupus erythematosus cell-positive and -negative sera.

G. Steiner, J. Smolen, G. Schett, 2000, Arthritis and rheumatism.

Murine models of systemic lupus erythematosus: B and T cell responses to spliceosomal ribonucleoproteins in MRL/Fas(lpr) and (NZB x NZW)F(1) lupus mice.

G. Steiner, S. Muller, H. Dumortier, 2001, International immunology.

Histone deposition and metabolism in embryonic chick lenses during differentiation.

M. Sanwal, Y. Courtois, J. Jeanny, 1992, Experimental eye research.

Specificity of antibodies raised against triacetylated histone H4.

M. V. Van Regenmortel, S. Muller, S. Plaue, 1987, Molecular immunology.

Anti‐SSA/Ro52 autoantibodies blocking the cardiac 5‐HT4 serotoninergic receptor could explain neonatal lupus congenital heart block

D. Isenberg, F. Lezoualc’h, R. Fischmeister, 2000, European journal of immunology.

Haemolysin‐derived synthetic peptides with pore‐forming and haemolytic activity

W. Goebel, R. Benz, S. Muller, 1992, Molecular microbiology.

Membrane expression of HIV envelope glycoproteins triggers apoptosis in CD4 cells.

M. Kieny, C. Dauguet, S. Muller, 1993, AIDS research and human retroviruses.

Characterization of monoclonal antibodies against alpha-hemolysin of Escherichia coli

W. Goebel, S. Muller, J. Briand, 1991, Infection and immunity.

Decision-making at the surface of the intact or barrier disrupted skin: potential applications for vaccination or therapy

S. Muller, C. Partidos, 2005, Cellular and Molecular Life Sciences CMLS.

Use of an immobilized enzyme and specific antibodies to analyse the accessibility and role of histone tails in chromatin structure.

M. V. Van Regenmortel, G. de Murcia, S. Muller, 1990, Biochemical and biophysical research communications.

A flavivirus protein M-derived peptide directly permeabilizes mitochondrial membranes, triggers cell death and reduces human tumor growth in nude mice

S. Muller, D. Chauvier, R. Casimir, 2009, Apoptosis.

HIV‐1 neutralizing antibodies elicited by the candidate CBD1 epitope vaccine react with the conserved caveolin‐1 binding motif of viral glycoprotein gp41

S. Muller, J. Briand, M. Rey-Cuillé, 2006, The Journal of pharmacy and pharmacology.

A retro-inverso peptide analogue of influenza virus hemagglutinin B-cell epitope 91-108 induces a strong mucosal and systemic immune response and confers protection in mice after intranasal immunization.

S. Muller, C. Partidos, T. Ben-Yedidia, 2002, Molecular immunology.

Modulation of deregulated chaperone-mediated autophagy by a phosphopeptide

A. Cuervo, S. Muller, J. Briand, 2015, Autophagy.

The importance of implementing proper selection of excipients in lupus clinical trials

S. Muller, D. Wallace, 2014, Lupus.

Peptide analogues as vaccines and immunomodulators

M. V. Regenmortel, S. Muller, H. Dumortier, 1999 .

A peptide vaccine administered transcutaneously together with cholera toxin elicits potent neutralising anti-FMDV antibody responses.

F. Brown, S. Muller, J. Briand, 2005, Veterinary immunology and immunopathology.

A synthetic HIV‐1 Tat protein breaches the skin barrier and elicits Tat‐neutralizing antibodies and cellular immunity

S. Muller, E. Moreau, J. Briand, 2004, European journal of immunology.

Peptide-based therapy in lupus: promising data.

S. Muller, F. Monneaux, 2007, Advances in experimental medicine and biology.

Extended Report

S. Muller, J. Briand, M. Decossas, 2022 .

Antitumor vaccination using a major histocompatibility complex (MHC) class I-restricted pseudopeptide with reduced peptide bond.

P. Kourilsky, J. Abastado, S. Muller, 2000, Journal of immunotherapy.

Immune response to hn and snRNP in autoimmune mice. A model for the development of lupus autoimmunity by a single initiator T helper epitope?

G. Steiner, S. Muller, H. Dumortier, 2001, Arthritis Research.

Cartilage-derived morphogenetic protein-1 and -2 are endogenously expressed and stimulate proteoglycan synthesis in healthy and osteoarthritic human articular chondrocytes

W. Robinson, L. Steinman, Andreas Radbruch, 2001, Arthritis Research.

P.298 Diminution des lymphocytes CD4+CD25high (Tregs) circulants au cours de la rectocolite hémorragique (RCH) : comparaison avec la maladie de Crohn colique (MC)

S. Muller, F. Monneaux, Z. Richert, 2009 .

An autophagy-targeting peptide to treat chronic inflammatory demyelinating polyneuropathies.

S. Brun, S. Muller, J. de Seze, 2018, Journal of autoimmunity.

A lipoyl synthetic octadecapeptide of dihydrolipoamide acetyltransferase specifically recognized by anti-M2 autoantibodies in primary biliary cirrhosis.

E. Penner, S. Muller, J. Briand, 1992, Journal of immunology.

Specificity and effect on apoptosis of Tat antibodies from vaccinated and SHIV-infected rhesus macaques and HIV-infected individuals.

A. Romieu, B. Roques, J. Zagury, 2003, Vaccine.

Disease Progression in MRL/lpr Lupus-Prone Mice Is Reduced by NCS 613, a Specific Cyclic Nucleotide Phosphodiesterase Type 4 (PDE4) Inhibitor

J. Bourguignon, S. Muller, F. Monneaux, 2012, PloS one.

Multiple autoepitope presentation for specific detection of antibodies in primary biliary cirrhosis

S. Muller, J. Briand, N. Tuaillon, 1992, Hepatology.

Peptido-targeting of the mitochondrial transition pore complex for therapeutic apoptosis induction.

S. Muller, E. Jacotot, J. Briand, 2006, Current pharmaceutical design.

Correction of autophagy impairment inhibits pathology in the NOD.H-2h4 mouse model of primary Sjögren's syndrome.

S. Muller, A. Qadri, E. Voynova, 2020, Journal of autoimmunity.

ATG5 is required for B cell polarization and presentation of particulate antigens

Johana Chicher, L. Kuhn, S. Muller, 2018, Autophagy.

Important B-cell epitopes for neutralization of human immunodeficiency virus type 1 Tat in serum samples of humans and different animal species immunized with Tat protein or peptides.

S. Muller, E. Moreau, C. Partidos, 2004, The Journal of general virology.

Induction of immune response against a short synthetic peptide antigen coupled to small neutral liposomes containing monophosphoryl lipid A.

M. V. Van Regenmortel, S. Muller, J. Briand, 1993, Molecular immunology.

T cell recognition and therapeutic effect of a phosphorylated synthetic peptide of the 70K snRNP protein administered in MR/lpr mice.

M. Patarroyo, S. Muller, F. Monneaux, 2003, European journal of immunology.

Histone Autoantibodies Other Than (H2A-H2B)-DNA Autoantibodies

S. Muller, C. Stemmer, 1996 .

Excipients: not so inert? When the excipient plays the role of an active substance, as exemplified by systemic lupus.

S. Muller, 2018, Swiss medical weekly.

Direct Visualization of Peptide/MHC Complexes at the Surface and in the Intracellular Compartments of Cells Infected In Vivo by Leishmania major

J. Cazareth, N. Glaichenhaus, E. Muraille, 2010, PLoS pathogens.

Importance of spliceosomal RNP1 motif for intermolecular T-B cell spreading and tolerance restoration in lupus

V. Parietti, S. Muller, F. Monneaux, 2007, Arthritis research & therapy.

Intramolecular T cell spreading in unprimed MRL/lpr mice: importance of the U1-70k protein sequence 131-151.

V. Parietti, S. Muller, F. Monneaux, 2004, Arthritis and rheumatism.

The potential of retro-inverso peptides as synthetic vaccines.

M. V. Van Regenmortel, F. Brown, S. Muller, 1998, Developments in biological standardization.

Apoptosis-linked changes in the phosphorylation status and subcellular localization of the spliceosomal autoantigen U1-70K

S. Muller, F. Monneaux, M. Decossas, 2008, Cell Death and Differentiation.

An active mechanism flanks and modulates the export of the small ribosomal subunits

E. Prosperi, S. Muller, M. Biggiogera, 2009, Histochemistry and Cell Biology.

D-peptides as immunogens and diagnostic reagents.

S. Muller, M. V. van Regenmortel, 1998, Current opinion in biotechnology.

Selective induction of protection against influenza virus infection in mice by a lipid-peptide conjugate delivered in liposomes.

S. Muller, J. Briand, B. Frisch, 1994, Vaccine.

Antigenicity and immunogenicity of modified synthetic peptides containing D-amino acid residues. Antibodies to a D-enantiomer do recognize the parent L-hexapeptide and reciprocally.

S. Muller, J. Briand, G. Guichard, 1993, The Journal of biological chemistry.

CD4+ T Cells from (New Zealand Black × New Zealand White)F1 Lupus Mice and Normal Mice Immunized Against Apoptotic Nucleosomes Recognize Similar Th Cell Epitopes in the C Terminus of Histone H31

S. Muller, B. Maillère, S. Fournel, 2003, The Journal of Immunology.

CD4 T Cells from (New Zealand Black New Zealand White)F1 Lupus Mice and Normal Mice Immunized Against Apoptotic Nucleosomes Recognize Similar Th Cell Epitopes in the C Terminus of Histone H3

S. Muller, B. Maillère, S. Fournel, 2003 .

Improvement of collagen-induced arthritis by active immunization against murine IL-1beta peptides designed by molecular modelling.

J. Zagury, S. Muller, J. Chomilier, 2005, Vaccine.

Targeting VEGF-A with a vaccine decreases inflammation and joint destruction in experimental arthritis

S. Muller, H. Hlawaty, E. Assier, 2015, Angiogenesis.

Nucleic acid-associated autoantigens: pathogenic involvement and therapeutic potential.

S. Muller, M. Hoffmann, S. Trembleau, 2010, Journal of autoimmunity.

The SARS-CoV-2 as an instrumental trigger of autoimmunity

Y. Shoenfeld, S. Muller, D. Kanduc, 2021, Autoimmunity Reviews.

Endotoxin‐free heat‐shock protein 70 fails to induce APC activation

D. Lipsker, J. Cazenave, S. Muller, 2002, European journal of immunology.

Asymmetry in Histone H3 variants and lysine methylation between paternal and maternal chromatin of the early mouse zygote

S. Muller, P. Boer, D. Braat, 2005, Mechanisms of Development.

Solid-phase synthesis of "mixed" peptidomimetics using Fmoc-protected aza-beta3-amino acids and alpha-amino acids.

S. Muller, A. Bondon, S. Chevance, 2005, The Journal of organic chemistry.

Antigenic properties and protective capacity of a cyclic peptide corresponding to site A of influenza virus haemagglutinin.

S. Muller, J. Briand, M. Valette, 1990, Vaccine.

An Overview of Novel Adjuvants Designed for Improving Vaccine Efficacy.

S. Muller, C. Partidos, Sylviane Muller, 2017, Trends in pharmacological sciences.

Synthetic peptides as antigens: pitfalls of conjugation methods.

S. Muller, M. V. Regenmortel, J. Briand, 1985, Journal of immunological methods.

Comparison of different methods for localizing antigenic regions in histone H2A.

S. Muller, S. Plaue, S. Muller, 1986, Molecular immunology.

Immunochemical detection of changes in chromatin subunits induced by histone H4 acetylation.

P. Sautière, S. Muller, M. Champagne, 1982, The EMBO journal.

Accessibility and structural role of histone domains in chromatin. biophysical and immunochemical studies of progressive digestion with immobilized proteases.

G. de Murcia, S. Muller, C. Marion, 1990, Journal of biomolecular structure & dynamics.

Histones and DNA ultrastructural distribution in plant cell nucleus: a combination of immunogold and cytochemical methods.

I. Raška, S. Muller, P. Testillano, 1998, Experimental cell research.

Use of antihistone antibodies with nucleosomes.

S. Muller, M. V. van Regenmortel, 1989, Methods in enzymology.

Antigenic structure of histone H2B.

P. Sautière, S. Muller, J. Briand, 1985, Biochimica et biophysica acta.

Immunochemical localization of the C‐terminal hexapeptide of histone H3 at the surface of chromatin subunits.

S. Muller, K. Himmelspach, M. V. van Regenmortel, 1982, The EMBO journal.

Synthetic peptides as antigens

S. Muller, S. Muller, M. H. Regenmortel, 1999 .

A retro-inverso peptide corresponding to the GH loop of foot-and-mouth disease virus elicits high levels of long-lasting protective neutralizing antibodies.

F. Brown, S. Muller, J. Briand, 1997, Proceedings of the National Academy of Sciences of the United States of America.

Application and limitations of the multiple antigen peptide (MAP) system in the production and evaluation of anti-peptide and anti-protein antibodies.

S. Muller, J. Briand, M. V. van Regenmortel, 1992, Journal of immunological methods.

Autophagy as an emerging target for COVID-19: lessons from an old friend, chloroquine

D. Klionsky, S. Muller, J. Bayry, 2020, Autophagy.

IgG antibodies from patients with primary Sjögren's syndrome and systemic lupus erythematosus recognize different epitopes in 60‐kD SSA/Ro protein

P. Youinou, S. Muller, J. Briand, 1992, Clinical and experimental immunology.

Lysosomes as a therapeutic target

S. Muller, Fengjuan Wang, S. Bonam, 2019, Nature Reviews Drug Discovery.

52-kDa Ro/SSA epitopes preferentially recognized by antibodies from mothers of children with neonatal lupus and congenital heart block

D. Isenberg, S. Muller, J. Hoebeke, 2005, Arthritis research & therapy.

MHC class II gene associations with autoantibodies to U1A and SmD1 proteins.

S. Muller, H. Dumortier, J. Briand, 1999, International immunology.

Comparison of two different methods using overlapping synthetic peptides for localizing linear B cell epitopes in the U1 snRNP-C autoantigen.

S. Muller, H. Dumortier, J. Briand, 1996, Journal of immunological methods.

Mapping of epitopes on Ul snRNP polypeptide A with synthetic peptides and autoimmune sera

S. Muller, J. Briand, M. H. Regenmortel, 1991, Clinical and experimental immunology.

Recognition of synthetic peptides of Sm‐D autoantigen by lupus sera

S. Muller, J. Briand, M. H. Regenmortel, 1990, Clinical and experimental immunology.

Antibodies from patients with rheumatoid arthritis and juvenile chronic arthritis analyzed with core histone synthetic peptides.

P. Youinou, S. Muller, P. Bordigoni, 1990, International archives of allergy and applied immunology.

Interaction between certain major histocompatibility complex class II and T-cell receptor V beta alleles promotes the antibody production to extractable nuclear antigen-related peptides.

J. Piette, B. Genetet, P. Youinou, 1997, Human immunology.

Genetic and environmental factors in Systemic lupus erythematosus

D. Isenberg, J. Piette, P. Youinou, 1994 .

Longitudinal analysis of antibodies to histones, Sm-D peptides and ubiquitin in the serum of patients with systemic lupus erythematosus, rheumatoid arthritis and tuberculosis.

D. Isenberg, S. Muller, R. Watts, 1990, Clinical and experimental rheumatology.

A branched, synthetic octapeptide of ubiquitinated histone H2A as target of autoantibodies

S. Muller, S. Plaue, M. V. van Regenmortel, 1989, The Journal of experimental medicine.

Pharmacological Autophagy Regulators as Therapeutic Agents for Inflammatory Bowel Diseases.

S. Muller, Sruthi Vijaya Retnakumar, 2019, Trends in molecular medicine.

Manipulating Autophagic Processes in Autoimmune Diseases: A Special Focus on Modulating Chaperone-Mediated Autophagy, an Emerging Therapeutic Target

S. Muller, Fengjuan Wang, 2015, Front. Immunol..

Selective Modulation of CD4+ T Cells from Lupus Patients by a Promiscuous, Protective Peptide Analog1

S. Muller, B. Maillère, F. Monneaux, 2005, The Journal of Immunology.

Selective Modulation of CD 4 T Cells from Lupus Patients by a Promiscuous , Protective Peptide Analog 1

S. Muller, B. Maillère, F. Monneaux, 2005 .

Cyclic GMP catabolism up-regulation in MRL/lpr lupus-prone mice is associated with organ remodeling.

S. Muller, M. Decossas, C. Lugnier, 2014, Biochimica et biophysica acta.

Generation and Characterization of Neutralizing Human Monoclonal Antibodies against Human Immunodeficiency Virus Type 1 Tat Antigen

Claude Desgranges, Johan Hoebeke, S. Muller, 2004, Journal of Virology.

Lysosomes in acute myeloid leukemia: potential therapeutic targets?

M. Tschan, S. McKenna, S. Muller, 2021, Leukemia.

Autophagy: A new concept in autoimmunity regulation and a novel therapeutic option.

S. Muller, Fengjuan Wang, S. Bonam, 2018, Journal of Autoimmunity.

Target Autophagy as a Novel Therapeutic Strategy in Autoimmune Diseases

S. Muller, Maud Wilhelm, 2016 .

TREM-1 Inhibition Restores Impaired Autophagy Activity and Reduces Colitis in Mice

P. Lepage, L. Peyrin-Biroulet, S. Danese, 2018, Journal of Crohn's & colitis.

Autophagy in neuroinflammatory diseases.

S. Brun, S. Muller, J. Loeffler, 2017, Autoimmunity reviews.

Spliceosomal peptide P140 for immunotherapy of systemic lupus erythematosus: results of an early phase II clinical trial.

S. Muller, F. Monneaux, J. Geiger, 2008, Arthritis and rheumatism.

HSPA8/HSC70 chaperone protein

F. Stricher, S. Muller, M. Ruff, 2013, Autophagy.

Progress and Challenges in the Use of MAP1LC3 as a Legitimate Marker for Measuring Dynamic Autophagy In Vivo

M. Tschan, S. Muller, S. Bonam, 2020, Cells.

Nuclei of aged myofibres undergo structural and functional changes suggesting impairment in RNA processing.

C. Zancanaro, S. Muller, C. Pellicciari, 2009, European journal of histochemistry : EJH.

Ikaros Is a Negative Regulator of B1 Cell Development and Function*

Philippe Kastner, P. Kastner, S. Muller, 2016, The Journal of Biological Chemistry.

Neuropsychiatric systemic lupus erythematosus and cognitive dysfunction: the MRL-lpr mouse strain as a model.

S. Muller, Hélène Jeltsch-David, 2014, Autoimmunity reviews.

Reactivity of autoantibodies in systemic lupus erythematosus with synthetic core histone peptides.

S. Muller, D. Bonnier, M. Thiry, 1989, International archives of allergy and applied immunology.

Single Insulin-Specific CD8+ T Cells Show Characteristic Gene Expression Profiles in Human Type 1 Diabetes

F. Lemonnier, J. Coste, C. Boitard, 2011, Diabetes.

The HIV-1 transcriptional activator Tat has potent nucleic acid chaperoning activities in vitro

C. Gabus, J. Darlix, Y. Mély, 2008, Nucleic acids research.

The N-terminus of HIV-1 Tat protein is essential for Tat-TAR RNA interaction

S. Muller, B. Masquida, S. Muller, 2005, Cellular and Molecular Life Sciences CMLS.

Localization of two antigenic determinants in histone H4.

S. Muller, J. Reinbolt, J. Bouley, 1983, Biochimica et biophysica acta.

pH-induced conformational changes in chromatin subunits measured by circular dichroism and immunochemical reactivity

S. Muller, M. H. Regenmortel, M. Erard, 1985 .

CD4 T cell autophagy is integral to memory maintenance

S. Muller, Johan Arnold, Diane Murera, 2018, Scientific Reports.

Synthetic Polypeptides As Antigens

S. Muller, M. H. Regenmortel, S. Plaue, 1988 .

Hepatoma tissue culture (HTC) cells as a model for investigating the effects of low concentrations of herbicide on cell structure and function.

S. Muller, M. Biggiogera, M. Malatesta, 2008, Toxicology in vitro : an international journal published in association with BIBRA.

Autoantibodies typical of non‐organ‐specific autoimmune diseases in HIV‐seropositive patients

L. Montagnier, S. Muller, J. Briand, 1992, AIDS.

The cytopathic effect of HIV is associated with apoptosis.

L. Montagnier, S. Muller, Y. Rivière, 1991, Virology.

The binding affinity of double‐stranded RNA motifs to HIV‐1 Tat protein affects transactivation and the neutralizing capacity of anti‐Tat antibodies elicited after intranasal immunization

Claude Desgranges, Johan Hoebeke, S. Muller, 2005, European journal of immunology.

Generation of self-peptides to treat systemic lupus erythematosus.

S. Muller, J. Briand, N. Schall, 2014, Methods in molecular biology.

Epigenetics of Autoantigens: New Opportunities for Therapy of Autoimmune Diseases

M. Radic, S. Muller, 2013, Genetics & epigenetics.

Lupus Regulator Peptide P140 Represses B Cell Differentiation by Reducing HLA Class II Molecule Overexpression

J. Sibilia, S. Muller, Fengjuan Wang, 2018, Arthritis & rheumatology.

Pharmacological regulators of autophagy and their link with modulators of lupus disease

S. Muller, F. Gros, 2014, British journal of pharmacology.

Autophagy in neuroin fl ammatory diseases

S. Brun, S. Muller, Hélène Jeltsch-David, 2022 .

Early Apoptotic Reorganization of Spliceosomal Proteins Involves Caspases, CAD and Rearrangement of NuMA

S. Muller, M. Decossas, V. Yuste, 2012, Traffic.

Automatic Sequence Design of Major Histocompatibility Complex Class I Binding Peptides Impairing CD8+ T Cell Recognition* 210

Alfonso Jaramillo, Shoshana J Wodak, S. Wodak, 2003, The Journal of Biological Chemistry.

TLR2 ligation protects effector T cells from regulatory T-cell mediated suppression and repolarizes T helper responses following MVA-based cancer immunotherapy

J. Bonnefoy, S. Muller, K. Rittner, 2012, Oncoimmunology.

A simple approach to cancer therapy afforded by multivalent pseudopeptides that target cell-surface nucleoproteins.

A. van Dorsselaer, J. Beyrath, P. Albanese, 2011, Cancer research.

Nuclei of aged myofibres undergo structural and functional changes suggesting impairment in RNA processing

C. Zancanaro, S. Muller, C. Pellicciari, 2009, European journal of histochemistry : EJH.

Transcriptionally inactive micronuclei, macronuclear anlagen and transcriptionally active macronuclei differ in histone composition in the hypotrichous ciliateStylonychia lemnae

S. Muller, M. Schlegel, W. Büsen, 1990, Chromosoma.

HIV-1 Tat and Apoptotic Death

S. Muller, C. Desgranges, C. Des̀granges, 2005 .

Immunization onto bare skin with heat‐labile enterotoxin of Escherichia coli enhances immune responses to coadministered protein and peptide antigens and protects mice against lethal toxin challenge

S. Muller, J. Briand, C. Partidos, 2001, Immunology.

Cationic carbon nanotubes bind to CpG oligodeoxynucleotides and enhance their immunostimulatory properties.

Maurizio Prato, Alberto Bianco, Johan Hoebeke, 2005, Journal of the American Chemical Society.

Glomerular immune deposits in murine lupus models may contain histones

Y. Sugisaki, A. Vogt, S. Muller, 1992, Clinical and experimental immunology.

Laboratory protocols for the identification of Th cell epitopes on self-antigens in mice with systemic autoimmune diseases.

S. Muller, F. Monneaux, 2000, Journal of immunological methods.

Mapping of linear histone regions exposed at the surface of the nucleosome in solution.

S. Muller, J. Briand, C. Stemmer, 1997, Journal of molecular biology.

Use of synthetic peptides for the analysis of B-cell epitopes in autoantigens

S. Muller, 1994 .

Autoantibodies to hnRNP-A2 in SLE: identification of disease-specific linear epitopes and correlation with disease activity and clinical features

J. Smolen, G. Schett, S. Muller, 2003, Arthritis Research & Therapy.

Specificity of Anti-Histone Autoantibodies in Systemic Rheumatic Disease

S. Muller, M. V. van Regenmortel, 1988 .

Recognition of Human Proinsulin Leader Sequence by Class I–Restricted T-Cells in HLA-A*0201 Transgenic Mice and in Human Type 1 Diabetes

F. Lemonnier, C. Boitard, S. Muller, 2009, Diabetes.

Immunoprevalence of the CD4+ T‐cell response to HIV Tat and Vpr proteins is provided by clustered and disperse epitopes, respectively

D. Houitte, S. Muller, B. Maillère, 2008, European journal of immunology.

Protection of swine from foot-and-mouth disease with one dose of an all-D retro peptide.

F. Brown, S. Muller, J. Briand, 1999, Vaccine.

The bare skin and the nose as non-invasive routes for administering peptide vaccines.

S. Muller, J. Briand, C. Partidos, 2001, Vaccine.

An Efficient Test Battery for Rapid Screening of Extrapyramidal Side-Effects of Phenothiazine Analogues

S. Muller, R. Amouroux, J. Peter, 2017 .

Structure of antibody-bound peptides and retro-inverso analogues. A transferred nuclear Overhauser effect spectroscopy and molecular dynamics approach.

S. Muller, J. Briand, G. Guichard, 2001, Biochemistry.

Molecular mimicry between SARS‐CoV‐2 and the female reproductive system

Y. Shoenfeld, S. Muller, D. Kanduc, 2021, American journal of reproductive immunology.

Structural and immunological characterisation of heteroclitic peptide analogues corresponding to the 600-612 region of the HIV envelope gp41 glycoprotein.

S. Muller, M. Jolivet, J. Briand, 2002, Journal of molecular biology.

B and T Cell Responses to the Spliceosomal Heterogeneous Nuclear Ribonucleoproteins A2 and B1 in Normal and Lupus Mice

G. Steiner, S. Muller, H. Dumortier, 2000 .

The HB-19 pseudopeptide 5[Kpsi(CH2N)PR]-TASP inhibits attachment of T lymophocyte- and macrophage-tropic HIV to permissive cells.

E. Dam, S. Nisole, S. Muller, 2000, AIDS research and human retroviruses.

IgG autoantibody response in HTLV-I-infected patients.

D. Smadja, S. Muller, G. Boire, 1995, Clinical Immunology and Immunopathology.

Induction of monocyte chemoattractant protein-1 (MCP-1/CCL2) gene expression by human immunodeficiency virus-1 Tat in human astrocytes is CDK9 dependent

S. Muller, O. Chaloin, M. Tardieu, 2010, Journal of NeuroVirology.

The Spliceosomal Phosphopeptide P140 Controls the Lupus Disease by Interacting with the HSC70 Protein and via a Mechanism Mediated by γδ T Cells

Alain Van Dorsselaer, A. van Dorsselaer, S. Muller, 2009, PloS one.

Apoptosis-induced acetylation of histones is pathogenic in systemic lupus erythematosus.

S. Muller, J. Briand, J. Berden, 2007, Arthritis and rheumatism.

Neuropsychiatric systemic lupus erythematosus: pathogenesis and biomarkers

S. Muller, Hélène Jeltsch-David, 2014, Nature Reviews Neurology.

Apoptosis-induced histone H3 methylation is targeted by autoantibodies in systemic lupus erythematosus

R. Voll, S. Muller, J. Berden, 2010, Annals of the rheumatic diseases.

Receptor–ligand and parasite protein–protein interactions in Plasmodium vivax: Analysing rhoptry neck proteins 2 and 4

H. Curtidor, S. Muller, O. Chaloin, 2018, Cellular microbiology.

All-D peptides recognized by an anti-carbohydrate antibody identified from a positional scanning library.

N. Greenspan, C. Pinilla, S. Muller, 1998, Journal of molecular biology.

[Autophagy in T and B cell homeostasis: recycling for sustainable growth].

S. Muller, Johan Arnold, F. Arbogast, 2016, Medecine sciences : M/S.

Identification of New Pathogenic Players in Lupus: Autoantibody-Secreting Cells Are Present in Nephritic Kidneys of (NZBxNZW)F1 Mice

S. Lacotte, S. Muller, H. Dumortier, 2010, The Journal of Immunology.

Spliceosomal Peptide P 140 for Immunotherapy of Systemic Lupus Erythematosus Results of an Early Phase II Clinical Trial

S. Muller, F. Monneaux, J. Geiger, 2008 .

Rituximab treatment overcomes reduction of regulatory iNKT cells in patients with rheumatoid arthritis.

V. Parietti, J. Sibilia, S. Muller, 2010, Clinical immunology.

Mapping of linear epitopes of human histone H1 recognized by rabbit anti-H1/H5 antisera and antibodies from autoimmune patients.

S. Muller, J. Briand, C. Stemmer, 1994, Molecular immunology.

Immunogenicity of free histones and of histones complexed with RNA.

S. Muller, J. Briand, M. Chaix, 1991, Molecular immunology.

Autoantibodies against Modified Histone Peptides in SLE Patients Are Associated with Disease Activity and Lupus Nephritis

R. Voll, S. Muller, J. Briand, 2016, PloS one.

Immunologically Inert Nanostructures as Selective Therapeutic Tools in Inflammatory Diseases

S. Muller, L. De Cola, E. Matsuura, 2021, Cells.

Presence of antibodies to ubiquitin during the autoimmune response associated with systemic lupus erythematosus.

S. Muller, J. Briand, M. H. Regenmortel, 1988, Proceedings of the National Academy of Sciences of the United States of America.

Mimotopes for lupus-derived anti-DNA and nucleosome-specific autoantibodies selected from random peptide phage display libraries: facts and follies.

C. Putterman, S. Muller, M. Monestier, 2005, Journal of immunological methods.

Human antinuclear autoantibodies crossreacting with the plasma membrane and the N-terminal region of histone H2B.

S. Muller, O. Rekvig, J. Briand, 1987, Immunological investigations.

Novel trisaccharide based phospholipids as immunomodulators.

S. Muller, Mallika Alvala, S. Bonam, 2019, International immunopharmacology.

Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

Sara W. Bird, Erinna F. Lee, Michael D. Kim, 2016 .

Immunomodulation by maternal autoantibodies of the fetal serotoninergic 5-HT4 receptor and its consequences in early BALB/c mouse embryonic development

F. Lezoualc’h, R. Fischmeister, S. Muller, 2007, BMC Developmental Biology.

Disulphide dimerised peptide creates a crystal contact in an anti-peptide antibody.

A. Aubry, E. Stura, S. Muller, 2002, Acta crystallographica. Section D, Biological crystallography.

Blocking nuclear export of HSPA8 after heat shock stress severely alters cell survival

L. Kuhn, S. Muller, P. Hammann, 2018, Scientific Reports.

Editorial :Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). DOI: 10.1080/15548627.2015.1100356;WOS:000373595400001; 2-s2.0-85013763791&;PMID: 26799652

Lee, Duchen, Izzo, 2016 .

A1.36 Active immunisation against peptides of vegf improves joint inflammation and destruction in collagen-induced arthritis

S. Muller, E. Assier, N. Schall, 2014 .

Characterization of a monoclonal antibody reacting with histone H3

S. Muller, E. Jockers-Wretou, C. Sekeris, 1985, FEBS letters.

The Antigenic Structure of Histones

M. V. Regenmortel, S. Muller, J. Briand, 1985 .

Anti-melanocortin-4 receptor autoantibodies in obesity.

S. Muller, M. Breidert, K. Hofbauer, 2009, The Journal of clinical endocrinology and metabolism.

Apoptosis-associated acetylation on histone H2B is an epitope for lupus autoantibodies.

S. Muller, J. Briand, M. Monestier, 2009, Molecular immunology.

Antibodies to histones in rheumatoid arthritis.

P. Youinou, S. Muller, J. Jouquan, 1988, Diagnostic and clinical immunology.

Post-translational modifications , subcellular relocation and release in apoptotic microparticles : apoptosis turns nuclear proteins into autoantigens

S. Muller, S. Muller, J. Dieker, 2009 .

Enhanced immunogenicity and cross-reactivity of retro-inverso peptidomimetics of the major antigenic site of foot-and-mouth disease virus.

F. Brown, S. Muller, J. Briand, 1995, Peptide research.

On the potential of retro-inverso peptides in vaccine design

S. Muller, J. Briand, 1998 .

HSC70 blockade by the therapeutic peptide P140 affects autophagic processes and endogenous MHCII presentation in murine lupus

S. Muller, J. Briand, M. Decossas, 2011 .

Anti-nucleosome antibodies and T-cell response in systemic lupus erythematosus.

S. Muller, S. Fournel, 2002, Annales de medecine interne.

Interplay of four idiotypes and interaction with autoantibodies in lupus patients, their relatives and their spouses.

D. Isenberg, J. Piette, Y. Shoenfeld, 1996, Journal of Autoimmunity.

Aberrant Expression of the Autoantigen Heterogeneous Nuclear Ribonucleoprotein-A2 (RA33) and Spontaneous Formation of Rheumatoid Arthritis-Associated Anti-RA33 Autoantibodies in TNF- Transgenic Mice

G. Kollias, G. Schett, S. Muller, 2005 .

B and T cell immune response to small nuclear ribonucleoprotein particles in lupus mice: autoreactive CD4+ T cells recognize a T cell epitope located within the RNP80 motif of the 70K protein

S. Muller, F. Monneaux, J. Briand, 2000, European journal of immunology.

Inhibition of HIV infection by pseudopeptides blocking viral envelope glycoprotein-mediated membrane fusion and cell death.

J. Blanco, S. Muller, E. Jacotot, 1996, Virology.

Blocking nuclear export of HSPA8 after heat shock stress severely alters cell survival

L. Kuhn, S. Muller, P. Hammann, 2018, Scientific Reports.

Immunogenicity of a liposome-associated synthetic hexapeptide antigen

S. Muller, J. Briand, B. Frisch, 1991 .